These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
206 related articles for article (PubMed ID: 20166126)
1. Differential regulation of steroid nuclear receptor coregulator expression between normal and neoplastic prostate epithelial cells. Heemers HV; Schmidt LJ; Kidd E; Raclaw KA; Regan KM; Tindall DJ Prostate; 2010 Jun; 70(9):959-70. PubMed ID: 20166126 [TBL] [Abstract][Full Text] [Related]
2. miR-17-5p targets the p300/CBP-associated factor and modulates androgen receptor transcriptional activity in cultured prostate cancer cells. Gong AY; Eischeid AN; Xiao J; Zhao J; Chen D; Wang ZY; Young CY; Chen XM BMC Cancer; 2012 Oct; 12():492. PubMed ID: 23095762 [TBL] [Abstract][Full Text] [Related]
3. Cell-line and tissue-specific signatures of androgen receptor-coregulator transcription. Bebermeier JH; Brooks JD; DePrimo SE; Werner R; Deppe U; Demeter J; Hiort O; Holterhus PM J Mol Med (Berl); 2006 Nov; 84(11):919-31. PubMed ID: 16932916 [TBL] [Abstract][Full Text] [Related]
4. MiR137 is an androgen regulated repressor of an extended network of transcriptional coregulators. Nilsson EM; Laursen KB; Whitchurch J; McWilliam A; Ødum N; Persson JL; Heery DM; Gudas LJ; Mongan NP Oncotarget; 2015 Nov; 6(34):35710-25. PubMed ID: 26461474 [TBL] [Abstract][Full Text] [Related]
5. New therapeutic approach to suppress castration-resistant prostate cancer using ASC-J9 via targeting androgen receptor in selective prostate cells. Lai KP; Huang CK; Chang YJ; Chung CY; Yamashita S; Li L; Lee SO; Yeh S; Chang C Am J Pathol; 2013 Feb; 182(2):460-73. PubMed ID: 23219429 [TBL] [Abstract][Full Text] [Related]
6. Expression of androgen receptor coregulators in prostate cancer. Linja MJ; Porkka KP; Kang Z; Savinainen KJ; Jänne OA; Tammela TL; Vessella RL; Palvimo JJ; Visakorpi T Clin Cancer Res; 2004 Feb; 10(3):1032-40. PubMed ID: 14871982 [TBL] [Abstract][Full Text] [Related]
7. Androgen modulation of coregulator expression in prostate cancer cells. Heemers HV; Regan KM; Schmidt LJ; Anderson SK; Ballman KV; Tindall DJ Mol Endocrinol; 2009 Apr; 23(4):572-83. PubMed ID: 19164447 [TBL] [Abstract][Full Text] [Related]
8. MDC1 functionally identified as an androgen receptor co-activator participates in suppression of prostate cancer. Wang C; Sun H; Zou R; Zhou T; Wang S; Sun S; Tong C; Luo H; Li Y; Li Z; Wang E; Chen Y; Cao L; Li F; Zhao Y Nucleic Acids Res; 2015 May; 43(10):4893-908. PubMed ID: 25934801 [TBL] [Abstract][Full Text] [Related]
9. Phenethyl isothiocyanate inhibits androgen receptor-regulated transcriptional activity in prostate cancer cells through suppressing PCAF. Yu C; Gong AY; Chen D; Solelo Leon D; Young CY; Chen XM Mol Nutr Food Res; 2013 Oct; 57(10):1825-33. PubMed ID: 23661605 [TBL] [Abstract][Full Text] [Related]
10. Oncogenic role of PinX1 in prostate cancer cells through androgen receptor dependent and independent mechanisms. Flores-Ramírez I; Rivas-Torres MÁ; Rodríguez-Dorantes M; Gutiérrez-Sagal R; Baranda-Avila N; Langley E J Steroid Biochem Mol Biol; 2021 Jun; 210():105858. PubMed ID: 33647521 [TBL] [Abstract][Full Text] [Related]
11. Androgen receptor as a regulator of ZEB2 expression and its implications in epithelial-to-mesenchymal transition in prostate cancer. Jacob S; Nayak S; Fernandes G; Barai RS; Menon S; Chaudhari UK; Kholkute SD; Sachdeva G Endocr Relat Cancer; 2014 Jun; 21(3):473-86. PubMed ID: 24812058 [TBL] [Abstract][Full Text] [Related]
12. A regulatory feedback loop between Ca2+/calmodulin-dependent protein kinase kinase 2 (CaMKK2) and the androgen receptor in prostate cancer progression. Karacosta LG; Foster BA; Azabdaftari G; Feliciano DM; Edelman AM J Biol Chem; 2012 Jul; 287(29):24832-43. PubMed ID: 22654108 [TBL] [Abstract][Full Text] [Related]
13. Corepressive function of nuclear receptor coactivator 2 in androgen receptor of prostate cancer cells treated with antiandrogen. Takeda K; Hara N; Nishiyama T; Tasaki M; Ishizaki F; Tomita Y BMC Cancer; 2016 May; 16():332. PubMed ID: 27225190 [TBL] [Abstract][Full Text] [Related]
14. Functional domain and motif analyses of androgen receptor coregulator ARA70 and its differential expression in prostate cancer. Hu YC; Yeh S; Yeh SD; Sampson ER; Huang J; Li P; Hsu CL; Ting HJ; Lin HK; Wang L; Kim E; Ni J; Chang C J Biol Chem; 2004 Aug; 279(32):33438-46. PubMed ID: 15166229 [TBL] [Abstract][Full Text] [Related]
15. Androgen receptor cofactors: A potential role in understanding prostate cancer. Li X; Xiong H; Mou X; Huang C; Thomas ER; Yu W; Jiang Y; Chen Y Biomed Pharmacother; 2024 Apr; 173():116338. PubMed ID: 38417290 [TBL] [Abstract][Full Text] [Related]
16. Elevation of androgen receptor promotes prostate cancer metastasis by induction of epithelial-mesenchymal transition and reduction of KAT5. Lin CY; Jan YJ; Kuo LK; Wang BJ; Huo C; Jiang SS; Chen SC; Kuo YY; Chang CR; Chuu CP Cancer Sci; 2018 Nov; 109(11):3564-3574. PubMed ID: 30142696 [TBL] [Abstract][Full Text] [Related]
17. Expression profiles and functional associations of endogenous androgen receptor and caveolin-1 in prostate cancer cell lines. Bennett NC; Hooper JD; Johnson DW; Gobe GC Prostate; 2014 May; 74(5):478-87. PubMed ID: 24375805 [TBL] [Abstract][Full Text] [Related]
18. Prostate cancer cells increase androgen sensitivity by increase in nuclear androgen receptor and androgen receptor coactivators; a possible mechanism of hormone-resistance of prostate cancer cells. Fujimoto N; Miyamoto H; Mizokami A; Harada S; Nomura M; Ueta Y; Sasaguri T; Matsumoto T Cancer Invest; 2007 Feb; 25(1):32-7. PubMed ID: 17364555 [TBL] [Abstract][Full Text] [Related]
19. Different expression of androgen receptor coactivators in human prostate. Fujimoto N; Mizokami A; Harada S; Matsumoto T Urology; 2001 Aug; 58(2):289-94. PubMed ID: 11489729 [TBL] [Abstract][Full Text] [Related]